ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

Cipla, DCL Polyesters, Goodlass Nerolac

CIPLA Gearing Up for Growth Indian pharma companies have to adopt a well-developed R and D base if they are to compete in the increasingly WTOdominated world. CIPLA is keen that government policy towards the intellectual property regime must safeguard the interest of the indigenous industry. Y K Hameid, CMD, says,

To read the full text Login

Get instant access

New 3 Month Subscription
to Digital Archives at

₹826for India

$50for overseas users

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top